Jennifer Pollak, MD
Urogynecology and Reconstructive Pelvic Surgery · Hollywood, FLNPI 1134328495
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,978 of the $3,999 with a category attached, or 74.5%. It is spread thinly across 28 manufacturers, the largest accounting for just 23.4%. Reporting peaked in 2023 at $1,603 and has fallen 70.3% since, to $476 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in FL, where the typical reported total is $5,437.
Across 115 payments — averaging $34.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Valencia Technologies Corporation$937
- Coloplast$642
- AbbVie$631
- Astellas Pharma US Inc$509
- Caldera Medical, Inc$252
- Hologic Sales And Service, LLC$120
- plus $908 from 22 others
What the payments were for
- Travel & lodging$80620%
- Food & beverage$2,97874%
- Education$2165%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Valencia Technologies Corporation | 4 | $937 |
| Coloplast | 10 | $642 |
| AbbVie(2 entities) | 33 | $631 |
| Astellas Pharma US Inc | 18 | $509 |
| Caldera Medical, Inc | 3 | $252 |
| Hologic Sales And Service, LLC | 5 | $120 |
| Therapeuticsmd, Inc. | 6 | $109 |
| Axonics, Inc. | 5 | $97 |
| Pfizer | 5 | $94 |
| Intuitive Surgical | 2 | $70 |
| Meditrina | 2 | $69 |
| Laborie Medical Technologies Corp. | 2 | $50 |
| Millicent US Inc | 2 | $45 |
| Integra Lifesciences Corporation | 1 | $43 |
| Coopersurgical, Inc. | 3 | $39 |
| Escala Medical Inc. | 1 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| 180 Medical, Inc. | 1 | $28 |
| Agile Therapeutics, Inc. | 1 | $25 |
| Provepharm Inc. | 1 | $25 |
| Urovant Sciences Inc | 1 | $23 |
| Kerecis Limited | 1 | $23 |
| Duchesnay USA Incorporated | 1 | $23 |
| Exeltis, USA Inc. | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Lupin Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- eCoin Device Kit$806
- ALTIS$279
- Desara$238
How this compares
$3,999 in reported general payments places this provider in the 40th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
See all urogynecology and reconstructive pelvic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 168 | $135,299 |
| GemtesaVibegron | 29 | $24,790 |
| Estradiol | 329 | $18,834 |
| PremarinEstrogens, Conjugated | 41 | $18,130 |
| Methenamine Hippurate | 172 | $17,746 |
| EstringEstradiol | 14 | $7,524 |
| Trospium Chloride ErTrospium Chloride | 17 | $3,036 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 99 | $1,373 |
| Terconazole | 27 | $716 |
| Solifenacin Succinate | 13 | $658 |
| Metronidazole | 11 | $618 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 26 | $349 |
| Fluconazole | 61 | $328 |
| Clobetasol Propionate | 23 | $284 |
| Gabapentin | 28 | $249 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $509 | $135,299168 claims |
| PfizerPremarin, Estring | $94 | $25,65455 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $29 | $24,79029 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
Other urogynecology and reconstructive pelvic surgery in Hollywood
- Nathan KowOrlando$116K
- Amir ShariatiCoconut Creek$106K
- Charbel SalamonOrlando$100K
- Allison WymanTampa$69K
- Nicole SzellLargo$54K
- Jose Lazaro WeissOviedo$28K
- Paul PettitJacksonville$27K
- Arash RahiCoconut Creek$23K
- Moises VirellesWellington$21K
- Marja SprockRockledge$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.